MY113560A - Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b - Google Patents

Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b

Info

Publication number
MY113560A
MY113560A MYPI92000358A MYPI19920358A MY113560A MY 113560 A MY113560 A MY 113560A MY PI92000358 A MYPI92000358 A MY PI92000358A MY PI19920358 A MYPI19920358 A MY PI19920358A MY 113560 A MY113560 A MY 113560A
Authority
MY
Malaysia
Prior art keywords
hepatitis
treatment
thiacytidine
deoxy
fluoro
Prior art date
Application number
MYPI92000358A
Inventor
Allen Furman Phillip
Robert Painter George Iii
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Emory filed Critical Univ Emory
Publication of MY113560A publication Critical patent/MY113560A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

THE USE OF A 1,3-OXATHIOLANE NUCLEOSIDE ANALOGUE AND PHARMACEUTICALLY ACCEPTABLE DERIVATIVES THEREOF FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS IS DISCLOSED. PHARMACEUTICAL FORMULATIONS ARE ALSO PROVIDED.
MYPI92000358A 1991-03-06 1992-03-05 Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b MY113560A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919104741A GB9104741D0 (en) 1991-03-06 1991-03-06 Therapeutic nucleosides

Publications (1)

Publication Number Publication Date
MY113560A true MY113560A (en) 2002-04-30

Family

ID=10691102

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI92000358A MY113560A (en) 1991-03-06 1992-03-05 Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b

Country Status (5)

Country Link
CA (1) CA2439322A1 (en)
GB (1) GB9104741D0 (en)
MY (1) MY113560A (en)
SA (1) SA92120445B1 (en)
ZA (1) ZA921658B (en)

Also Published As

Publication number Publication date
CA2439322A1 (en) 1992-09-17
ZA921658B (en) 1993-09-06
SA92120445B1 (en) 2005-10-05
GB9104741D0 (en) 1991-04-17

Similar Documents

Publication Publication Date Title
EP1808434A3 (en) Use of 5-fluoro-2'-deoxy-3'-thiacytidine fo the treatment of hepatitis B
TW366347B (en) Antiviral pharmaceutical compositions comprising 1,3-oxathiolane nucleoside analogues
MY109796A (en) 1,3-oxathiolane nucleoside analogues.
AU591125B2 (en) Therapeutic nucleosides
MY107843A (en) Anti-viral compounds.
IL101836A0 (en) Pharmaceutical compositions containing 1,3-oxathiolane nucleoside derivatives
EE02995B1 (en) Use of 1,3-oxathiolane nucleoside analogues for the preparation of hepatitis B drugs
DE69230140T2 (en) ANTIVIRAL NUCLEOSIDE COMBINATION
WO2003063771A3 (en) N4-acylcytosine nucleosides for treatment of viral iinfections
RU93043875A (en) 1- (2-HYDROXYMETHYL) -1,3-OXATIOLAN-5-IL) -5-fluorocytosine AND METHOD OF TREATMENT
MY127808A (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
ATE131730T1 (en) ANTI-VIRUS PREPARATIONS CONTAINING NUCLEOSIDE ANALOGUES
TW371662B (en) Antiviral acyclic phosphonomethoxyalkyl substituted alkenyl purine and pyrimidine derivatives
EA200100494A1 (en) Synthesis, anti-human immunodeficiency virus and anti-hepatitis b virus activities of 1,3-oxaselenolane nucleosides
MY137298A (en) Therapeutic nucleosides
MY113560A (en) Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b
RU93058325A (en) APPLICATION OF 1,3-OXATHIOLANE DERIVATIVES FOR PRODUCTION OF MEDICINES FOR THE TREATMENT OR PREVENTION OF HEPATITIS B VIRAL INFECTION, APPLICATION OF 1,3 - OXATHYOLANE DERIVATIVES FOR THE TREATMENT OF HEPATITIS
SE9602262D0 (en) New use of cystine derivatives
IL138098A (en) Use of lamivudine or pharmaceutically acceptable derivatives thereof for the manufacture of pharmaceutical compositions for use in the treatment or prophylaxis of viral infections
TH13799EX (en) Anti-HBV Pyrimidine Nucleoside